Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2015 | Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B? | Lin C.-L.; JIA-HORNG KAO | Hepatology (Baltimore, Md.) | 1 | 1 | |
2009 | Capsule endoscopy versus colonoscopy | Hsu C.-S.; JIA-HORNG KAO | New England Journal of Medicine | 0 | ||
2010 | Carvedilol versus variceal band ligation for prevention of the first variceal bleed | Wang C.-C.; JIA-HORNG KAO | Hepatology | 0 | 0 | |
2021 | The case for simplifying and using absolute targets for viral hepatitis elimination goals | Razavi H.; Blach S.; Razavi-Shearer D.; Abaalkhail F.; Abbas Z.; Abdallah A.; Abrao Ferreira P.; Abu Raddad L.J.; Adda D.; Agarwal K.; Aghemo A.; Ahmed A.; Al-Busafi S.A.; Al-hamoudi W.; Al-Kaabi S.; Al-Romaihi H.; Aljarallah B.; AlNaamani K.; Alqahtani S.; Alswat K.; Altraif I.; Asselah T.; Bacon B.; Bessone F.; Bizri A.R.; Block T.; Bonino F.; Brandão-Mello C.E.; Brown K.; Bruggmann P.; Brunetto M.R.; Buti M.; Cabezas J.; Calleja J.L.; Castro Batänjer E.; Chan H.L.-Y.; Chang H.; Chen C.-J.; Christensen P.B.; Chuang W.-L.; Cisneros L.; Cohen C.; Colombo M.; Conway B.; Cooper C.; Craxi A.; Crespo J.; Croes E.; Cryer D.; Cupertino de Barros F.P.; Derbala M.; Dillon J.; Doss W.; Dou X.; Doyle J.; Duberg A.-S.; Dugan E.; Dunn R.; Dusheiko G.; El Khayat H.; El-Sayed M.H.; Eshraghian A.; Esmat G.; Esteban Mur R.; Ezzat S.; Falconer K.; Fassio E.; Ferrinho P.; Flamm S.; Flisiak R.; Foster G.; Fung J.; García-Samaniego J.; Gish R.G.; Gonçales F.; Halota W.; Hamoudi W.; Hassany M.; Hatzakis A.; Hay S.; Himatt S.; Hoepelman I.M.; Hsu Y.-C.; Hui Y.T.; Hunyady B.; Jacobson I.; Janjua N.; Janssen H.; Jarcuska P.; Kabagambe K.; Kanto T.; JIA-HORNG KAO ; Kaymakoglu S.; Kershenobich D.; Khamis F.; Kim D.J.; Kim D.Y.; Kondili L.A.; Kottilil S.; Kramvis A.; Kugelmas M.; Kurosaki M.; Lacombe K.; Lagging M.; Lao W.-C.; Lavanchy D.; Lazarus J.V.; Lee A.; Lee S.S.; Levy M.; Liakina V.; Lim Y.-S.; Liu S.; Maddrey W.; Malekzadeh R.; Marinho R.T.; Mathur P.; Maticic M.; Mendes Correa M.C.; Mera J.; Merat S.; Mogawer S.; Mohamed R.; Muellhaupt B.; Muljono D.; Mostafa I.; Nahum M.S.; Nawaz A.; Negro F.; Ninburg M.; Ning Q.; Ntiri- Reid B.; Nymadawa P.; Oevrehus A.; Ormeci N.; Orrego M.; Osman A.; Oyunsuren T.; Pan C.; Papaevangelou V.; Papatheodoridis G.; Popping S.; Prasad P.; Prithiviputh R.; Qureshi H.; Ramji A.; Razavi-Shearer K.; Reddy R.; Remak W.; Richter C.; Ridruejo E.; Robaeys G.; Roberts S.; Roberts L.; Roudot-Thoraval F.; Saab S.; Said S.; Salamat A.; Sanai F.; Sanchez-Avila J.F.; Schiff E.; Schinazi R.; Sebastiani G.; Seguin-Devaux C.; Shanmugam R.P.; Sharara A.; Shilton S.; Shouval D.; Sievert W.; Simonova M.; Sohrabpour A.A.; Sonderup M.; Soza A.; Wendy Spearman C.; Steinfurth N.; Sulkowski M.; Tan S.-S.; Tanaka J.; Tashi D.; Thein H.-H.; Thompson P.; Tolmane I.; Toy M.; Valantinas J.; Van de Vijver D.; Vélez-Möller P.; Vince A.; Waked I.; Wang S.; Wedemeyer H.; Wong V.; Xie Q.; Yamada S.; Yang H.-I.; Yesmembetov K.; Yilmaz Y.; Younossi Z.; Yu M.-L.; Yuen M.-F.; Yurdaydin C.; Yusuf A.; Zekry A.; Zeuzem S.; Polaris Observatory Collaborators | Journal of Viral Hepatitis | 25 | 22 | |
2006 | Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C | Yang S.-S.; Fu L.-S.; Chang C.-S.; Yeh H.-Z.; Chen G.-H.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 17 | 17 | |
2005 | Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia | JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 100 | 88 | |
2021 | Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study | Yu M.-L.; Tsai W.-L.; Chu C.-J.; JIA-HORNG KAO | Kaohsiung Journal of Medical Sciences | 1 | 1 | |
2016 | Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model | Li Y.-T.; CHUN-JEN LIU ; TUNG-HUNG SU ; Cheng H.-R.; YUNG-MING JENG ; Lin H.-L.; Wang C.-C.; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN ; Wu H.-L. | Oncotarget | 4 | 4 | |
2019 | Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 29 | 26 | |
1996 | Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay: A clinicopathologic study and demonstration of the usefulness of a third-generation assay | JIA-HORNG KAO ; Lai M.-Y.; Hwang Y.-T.; PEI-MING YANG ; PEI-JER CHEN ; JIN-CHUAN SHEU ; Wang T.-H.; Hsu H.-C.; DING-SHINN CHEN | Digestive Diseases and Sciences | 48 | 44 | |
2021 | Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease | SHANG-CHIN HUANG ; Su H.-J; JIA-HORNG KAO ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; CHUN-JEN LIU | Gut and Liver | 38 | 32 | |
2012 | Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid | BANG-BIN CHEN ; CHAO-YU HSU ; CHIH-WEI YU ; Wei S.-Y.; JIA-HORNG KAO ; Lee, Hsuan-Shu ; TIFFANY TING-FANG SHIH | Investigative Radiology | 16 | 18 | |
2002 | Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Clinical Microbiology | 84 | 79 | |
2014 | Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously | Cheng H.-R.; JIA-HORNG KAO ; Wu H.-L.; Chen T.-C.; TAI-CHUNG TSENG ; CHEN-HUA LIU ; TUNG-HUNG SU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU | Liver International | 13 | 11 | |
2003 | Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: A prospective study | CHUN-JEN LIU ; PEI-JER CHEN ; Shau W.-Y.; JIA-HORNG KAO ; Lai M.-Y.; DING-SHINN CHEN | Liver International | 24 | 22 | |
2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee M.-H.; Huang C.-F; Lai H.-C; Lin C.-Y; Dai C.-Y; CHUN-JEN LIU ; Wang J.-H; Huang J.-F; Su W.-P; HUNG-CHIH YANG ; Kee K.-M; Yeh M.-L; Chuang P.-H; SHIH-JER HSU ; Huang C.-I; JIA-HORNG KAO ; CHIEH-CHANG CHEN ; Chen S.-H; Jeng W.-J; Yang H.-I; Yuan Y; Lu S.-N; Sheen I.-S; CHEN-HUA LIU ; Peng C.-Y; Yu M.-L; Chuang W.-L; Chen C.-J. | Scientific Reports | 16 | 14 | |
2019 | Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotyping | JIA-HORNG KAO ; Lin C.-Y.; Chuang W.-L.; Cheng Y.-Y.; Hu J.-Y.; Liang W.-K.; Friebe P.; Palmer S.; Huang C.-S. | Diagnostic Microbiology and Infectious Disease | 2 | 2 | |
2007 | Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy | WANG-HUEI SHENG ; CHIEN-CHING HUNG ; Wu R.-J.; JANN-TAY WANG ; PEI-JER CHEN ; SHAN-CHWEN CHANG ; JIA-HORNG KAO | Clinical Infectious Diseases | 10 | 8 | |
2011 | The clinical implications of hepatitis B virus genotype: Recent advances | Lin C.-L.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 296 | 266 | |
2010 | Clinical implications of hepatitis B virus variants | Lin C.-L.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 8 | 8 |